Lilavati Hospital Doctors Save Life of 78-Year-Old Woman with Serious Heart Disease
Mumbai (Maharashtra) [India], June 17: Lilavati Hospital have successfully saved the life of a 78-year-old woman suffering from a serious heart condition known as Mitral Annular Calcification. The patient received a new lease on life through a Transcatheter Transatrial Mitral Valve Replacement (TMVR) surgery. This procedure, performed at Lilavati Hospital in Mumbai, marks India's first successful transatrial TMVR surgery. India's First Successful Transcatheter Transatrial Mitral Valve Replacement Surgery Performed at Lilavati Hospital.
The surgery was conducted by a team of specialists led by Dr. Ravinder Singh Rao, Interventional Structural Cardiologist, Dr. Kaushal Pandey, Cardiac Surgeon, and Dr. Uday Gandhi, Cardiac Anaesthesist.
Sujata Sakpal (Name changed), had been suffering from severe breathlessness for months. She couldn't sleep lying down and experienced discomfort while eating, walking, or even bathing. Despite undergoing treatment from several doctors, there was no improvement. Realizing the seriousness of her condition, the family admitted her to Lilavati Hospital. Medical tests revealed that her mitral valve was damaged and heavily calcified. Considering her age, the condition of her lungs, and the extensive calcification in her heart, a traditional surgery was deemed extremely risky. Many other hospitals had declined to perform the procedure.
However, doctors at Lilavati Hospital took up the challenge and opted for the advanced TMVR procedure.
Dr. Ravinder Singh Rao, Interventional Structural Cardiologist, Lilavati Hospital Mumbai said, "Given her age and frail condition, traditional surgery was not an option. So, we chose the Transcatheter Transatrial Mitral Valve Replacement technique. We used an Edwards Sapien 3 valve for the replacement. A small incision was made in the heart to remove the damaged valve and implant the new one. The entire procedure was completed in a very short time. The patient was kept in the ICU for just one day and discharged within four days as her condition improved. Three months later, she is now able to walk again, sleeps well, and lives independently without any breathing issues."
"This procedure offers a ray of hope to patients for whom traditional treatment is not possible," concluded Dr. Rao.
Dr. Niraj Uttamani, COO of Lilavati Hospital Mumbai said, "This surgery is not just a medical achievement but a landmark for India and the entire Asian continent. It reflects Lilavati's commitment to medical excellence and brings new hope to patients suffering from critical illnesses."
Sharing her feelings, Patient Sujata Sakpal said, "I had breathing problems for many years. I couldn't sleep or even eat properly. Other doctors had refused surgery, and I was scared. But the doctors at Lilavati Hospital treated me in time and gave me a second chance at life. I'm deeply grateful to them."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
17 hours ago
- Business Standard
Hexaware Appoints Shantanu Baruah to Lead Healthcare, Life Sciences, and Insurance Globally
PRNewswire Iselin (New Jersey) [US], August 1: Hexaware Technologies (NSE: HEXT), a global IT solutions company, today announced the appointment of Shantanu Baruah as President & Global Head - Healthcare, Life Sciences & Insurance (H & I). He will be based out of the company's New Jersey office and will lead Hexaware's global strategy, growth, and client success initiatives across the vertical. With over 25 years of experience in the healthcare and life sciences industry, Shantanu brings deep domain expertise and a proven track record of building high-performing teams, driving strategic growth, and leading complex client transformations. Prior to joining Hexaware, he served as Executive Vice President at HCLTech, where he led the Healthcare vertical during one of the industry's most disruptive periods and played a pivotal role in expanding business in the Americas. At a time when AI is reshaping everything from drug discovery to diagnostics and preventive care, Shantanu's appointment underscores Hexaware's commitment to delivering real-world impact. With AI and data at the core, Hexaware is focused on helping clients enhance patient outcomes, accelerate innovation, and drive operational efficiencies -- critical pillars shaping the future of healthcare. R Srikrishna, CEO of Hexaware, said, "We're excited to have Shantanu join Hexaware at a time of exciting momentum in our Healthcare, Life Sciences, and Insurance business. His leadership and deep market knowledge will be instrumental in helping our clients navigate the next era of digital health, patient-centric care, and AI-powered innovation." Commenting on his appointment, Shantanu Baruah said, "I'm delighted to join Hexaware and lead the next phase of growth in the H & I vertical. The industry is at an inflection point, and Hexaware's agile culture, customer-first mindset, and AI-led and human intelligence perfected approach make it ideally positioned to partner with clients in delivering better outcomes." Shantanu holds a master's degree in computer applications and a bachelor's degree in zoology, a combination that brings both technical and scientific perspectives to his leadership. This appointment reflects Hexaware's continued focus on strengthening domain leadership and scaling vertical-centric growth to address the evolving needs of global clients. About Hexaware Hexaware is a global technology and business process services company. Every day, Hexawarians wake up with a singular purpose: to create smiles through great people and technology. With offices across the world, we empower enterprises worldwide to realize digital transformation at scale and speed by partnering with them to build, transform, run, and optimize their technology and business processes. Learn more about Hexaware at Photo: Logo:
India Today
21 hours ago
- India Today
India's lung cancer burden in numbers
Lung cancer, mostly caused by smoking tobacco, has become the top reason for cancer-related deaths around the world, and even in India. What makes it more dangerous is that it often goes unnoticed until it reaches a serious like a long-lasting cough or chest pain usually appear late, which means treatment options become limited. In India, one in nine people is expected to get cancer during their lifetime, and lung cancer is becoming more common every number of lung cancer cases in India is rising, from about 63,700 cases in 2015 to a projected 81,200 cases in 2025. Around 100 million adults in the country smoke, which puts a huge population at risk. Every year, nearly 60,000 people in India die because of lung cancer. Globally, in 2020, lung cancer was the second most common cancer and the leading cause of cancer deaths. These numbers highlight the urgent need for awareness, early detection, and strong efforts to reduce tobacco use. According to the Population Based Cancer Registries Report 2016, lung cancer cases are highest in India's northeastern from the National Cancer Registry Programme shows that lung cancer rates among men range from 4.6 per 100,000 in Wardha to 38.8 in Aizawl. Among women, the rates range from 1 in Barshi to 37.9 in comparison, the western and central parts of India have fewer lung cancer cases. This difference may be due to the varying smoking habits in different regions. Overall, about 18.9% of India's population smokes, but the numbers differ widely — from 16.2% in Kerala to as high as 72% in Mizoram. Lung-cancer patterns in India look a lot like those in other Asian countries such as people here get the disease than in Western nations, yet they tend to be diagnosed about ten years earlier. Sadly, more of them die from it: many discover the cancer only after it has spread, arrive at clinics or hospitals in poorer health, and often cannot access the newest is a main driver. The latest Global Adult Tobacco Survey shows that 28.6% of Indians aged 15-24 smoke regularly, and the country has about 253 million tobacco users overall - one of the highest totals in the world. In India, lung cancer is more common in males than in females. In 2020, an estimated 71,788 men and 26,490 women were diagnosed with the disease. By 2025, the number of cases is expected to rise, with projections showing 81,219 cases in men and 30,109 in growing trend highlights the need for stronger prevention, early detection, and awareness efforts, especially among high-risk groups. With lung cancer cases steadily rising, with nearly one in four patients in India being non-smokers, there is an urgent need for early intervention, greater public awareness, and stronger policies that promote cleaner air and healthier lifestyles.- EndsMust Watch
Time of India
a day ago
- Time of India
Vaping, hookah and heredity: The new-age triggers for lung cancer
Traditional risk factors like smoking cigarettes, being exposed to asbestos, or having air pollution for an extended period of time have long been linked to lung cancer. But as new-age triggers like vaping, hookah use, and genetic risk start to gain traction, particularly among younger people and non-smokers, the discourse is changing. Vaping: An unspoken risk Vaping is being marketed as a less harmful alternative to smoking cigarettes, and it has swiftly gained popularity among young adults. Many researchers now say that vaping is not harmless by any means. Vaping has been found to contain nicotine, formaldehyde, volatile organic compounds, carcinogens and other poisons that are aspirated into the lungs during vaping. These substances damage lung tissue, cause inflammation, and increase the likelihood of stimuli creating cellular changes that can also contribute to increases in lung cancer. In addition, a number of vaping liquids have flavorings that give off toxic by-products when heated. Studies are exploring if vaping suppresses lung immune function worsening the damage of the lung tissue that leads to future cancers. Hookah: Not a safe alternative Hookah is commonly, as a social and accepted way to smoke tobacco, popularly misinterpreted to be less harmful than smoking cigarettes. However, a hookah smoking session can involve inhaling 100-200 times the volume of smoke of smoking a single cigarette (Blue 219).The smoke also contains tar, carbon monoxide, heavy metals, and other chemicals linked to the causes of cancer. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Pierce Brosnan's Wife Lost 120 Pounds - This Is Her Now Undo Due to the fact that hookah smoking normally involves a longer period of time, the increased exposure to toxins may prove to be even more lung-threatening. The social aspect of hookah also makes it more likely to catch respiratory infections, which further weaken lungs. Heredity: The forgotten risk Although lifestyle continues to be the primary cause of lung cancer, genetics are also a significant contributor, particularly in non-smokers. A person with a family history of lung cancer can have genes that predispose them to lung cancer, even without apparent environmental causes. In a few instances, hereditary lung cancers are associated with EGFR (epidermal growth factor receptor) mutations, which occur more frequently in younger, non-smoking Asian women. Detection of genetic susceptibility by tumor testing or family screening is becoming a significant component of individualized cancer treatment. The face of lung cancer is changing. It's no longer just about long-term cigarette use; newer lifestyle choices like vaping and hookah, combined with genetic predispositions, are expanding the at-risk population. Awareness, early detection, and preventive action — including quitting harmful habits and undergoing genetic counseling when needed — are essential in tackling this evolving public health challenge. Dr. Rajesh Mistry, Senior Director (Group), Oncology, Kokilaben Dhirubhai Ambani Hospital, Mumbai
